Compare with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR LALCHANDANI LABS vs THYROCARE TECHNOLOGIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR LALCHANDANI LABS THYROCARE TECHNOLOGIES DR LALCHANDANI LABS/
THYROCARE TECHNOLOGIES
 
P/E (TTM) x - 24.2 - View Chart
P/BV x 1.8 11.6 15.2% View Chart
Dividend Yield % 0.0 2.7 -  

Financials

 DR LALCHANDANI LABS   THYROCARE TECHNOLOGIES
EQUITY SHARE DATA
    DR LALCHANDANI LABS
Mar-21
THYROCARE TECHNOLOGIES
Mar-21
DR LALCHANDANI LABS/
THYROCARE TECHNOLOGIES
5-Yr Chart
Click to enlarge
High Rs181,212 1.4%   
Low Rs7485 1.4%   
Sales per share (Unadj.) Rs22.693.6 24.1%  
Earnings per share (Unadj.) Rs2.321.4 10.9%  
Cash flow per share (Unadj.) Rs3.527.1 13.0%  
Dividends per share (Unadj.) Rs025.00 0.0%  
Avg Dividend yield %02.9 0.0%  
Book value per share (Unadj.) Rs22.180.3 27.5%  
Shares outstanding (eoy) m4.3352.87 8.2%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.59.1 5.9%   
Avg P/E ratio x5.239.6 13.1%  
P/CF ratio (eoy) x3.431.3 11.0%  
Price / Book Value ratio x0.610.6 5.2%  
Dividend payout %0116.7 0.0%   
Avg Mkt Cap Rs m5344,869 0.1%   
No. of employees `000NANA-   
Total wages/salary Rs m4581 0.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m984,946 2.0%  
Other income Rs m0124 0.0%   
Total revenues Rs m985,071 1.9%   
Gross profit Rs m221,713 1.3%  
Depreciation Rs m5303 1.7%   
Interest Rs m49 40.8%   
Profit before tax Rs m141,525 0.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4393 0.9%   
Profit after tax Rs m101,132 0.9%  
Gross profit margin %23.034.6 66.4%  
Effective tax rate %26.625.8 103.1%   
Net profit margin %10.322.9 45.2%  
BALANCE SHEET DATA
Current assets Rs m862,381 3.6%   
Current liabilities Rs m29951 3.0%   
Net working cap to sales %58.228.9 201.3%  
Current ratio x3.02.5 119.1%  
Inventory Days Days43107 40.4%  
Debtors Days Days148,580,23133 450,636,818.6%  
Net fixed assets Rs m643,020 2.1%   
Share capital Rs m43529 8.2%   
"Free" reserves Rs m523,715 1.4%   
Net worth Rs m964,243 2.3%   
Long term debt Rs m260-   
Total assets Rs m1525,402 2.8%  
Interest coverage x4.9176.3 2.8%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.60.9 70.3%   
Return on assets %9.021.1 42.6%  
Return on equity %10.626.7 39.7%  
Return on capital %14.236.2 39.3%  
Exports to sales %00-   
Imports to sales %00.7 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA33 0.0%   
Fx inflow Rs m052 0.0%   
Fx outflow Rs m033 0.0%   
Net fx Rs m018 0.0%   
CASH FLOW
From Operations Rs m121,160 1.0%  
From Investments Rs m-23-502 4.5%  
From Financial Activity Rs m17-616 -2.8%  
Net Cashflow Rs m642 15.1%  

Share Holding

Indian Promoters % 60.8 71.2 85.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 18.7 -  
FIIs % 0.0 12.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 39.2 28.8 136.1%  
Shareholders   151 65,769 0.2%  
Pledged promoter(s) holding % 0.0 100.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR LALCHANDANI LABS With:   FORTIS HEALTHCARE    INDRAPRASTHA MEDICAL    DR. LAL PATHLABS    MAX HEALTHCARE INSTITUTE    METROPOLIS HEALTHCARE    



Today's Market

SGX Nifty Tanks 294 Points, Maruti Suzuki Quarterly Results, Oyo's Rs 84 bn IPO, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a positive note on Tuesday. Benchmark indices snapped their five-day losing run and ended on a positive note in a highly volatile session.

Related Views on News

THYROCARE TECHNOLOGIES 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of THYROCARE TECHNOLOGIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of THYROCARE TECHNOLOGIES. Also includes updates on the valuation of THYROCARE TECHNOLOGIES.

What Led to the Recent Surge in Shares of Thyrocare Technologies? (Views On News)

Jun 26, 2021

Shares of Thyrocare Technologies rallied over 7% and touched an all time high of Rs 1,465 on the BSE yesterday.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here...(Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR LALCHANDANI LABS SHARE PRICE


Jan 24, 2022 (Close)

TRACK DR LALCHANDANI LABS

  • Track your investment in DR LALCHANDANI LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR LALCHANDANI LABS

DR LALCHANDANI LABS - KRSNAA DIAGNOSTICS COMPARISON

COMPARE DR LALCHANDANI LABS WITH

MARKET STATS